Helus Pharma Inc.
HELP | NASDAQ
$10.60
-$0.11 (-1.03%)
At close: Oct 30, 2026, 4:00 PM ET
$10.77
+$0.17 (+1.60%)
Pre-market:
Nov 2, 2026, 7:09 AM ET
Market Data
Market Cap $656.72M
Enterprise Value $490.56M
Beta 0.54
Average Volume 1.75M
Shares Outstanding (Diluted) 52.32M
Shares Change YoY 133.55%
Institutional Ownership N/A
Exchange NASDAQ
ISIN CA4234921076
Price Performance
Price Change 1M -13.8%
Price Change 3M 35.5%
Price Change 6M 105.8%
Price Change YTD 29.6%
Price Change 1Y N/A
Price Change 3Y N/A
Price Change 5Y N/A
1M CAGR (ann.) -14.3%
1Y CAGR (ann.) N/A
5Y CAGR (ann.) N/A
All-Time CAGR 92.3%
Valuation
PE Ratio -1.92
Forward PE N/A
PEG Ratio -0.11
Forward PEG 0.08
PS Ratio N/A
Forward PS 20.70
PB Ratio 2.72
P/FCF Ratio -4.25
P/Adj. FCF Ratio -4.12
P/OCF Ratio -3.98
EV/Sales N/A
EV/EBIT -2.77
EV/EBITDA -2.77
EV/FCF -3.17
Earnings Yield -52.0%
FCF Yield -23.5%
Adj. FCF Yield -24.3%
Financial Health
Net Cash $166.17M
Total Debt $0
Cash & Short-Term Investments $166.17M
Total Assets $259.34M
Current Ratio 10.97
Quick Ratio 10.97
Debt / Equity Ratio 0.00
Debt / EBITDA -0.00
Debt / FCF -0.00
OCF / Debt N/A
Interest Coverage 0.00
Altman Z-Score 18.65
Piotroski F-Score 4
Margins & Profitability
Gross Profit Margin 0.0%
Operating Profit Margin 0.0%
EBITDA Margin 0.0%
Net Profit Margin 0.0%
FCF Margin N/A
Adj. FCF Margin N/A
SBC / Revenue 0.0%
SBC Impact (per share) -3.2%
Returns
Return on Assets -67.6%
Return on Equity -74.5%
Return on Invested Capital -70.8%
Return on Capital Employed -70.8%
Return on Tangible Assets -91.0%
Historical Growth (CAGR)
Revenue CAGR 3Y -151.6%
Revenue CAGR 5Y -102.2%
Revenue CAGR 10Y N/A
EPS CAGR 3Y 12.1%
EPS CAGR 5Y 25.7%
EPS CAGR 10Y N/A
FCF CAGR 3Y -34.3%
FCF CAGR 5Y -30.3%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Buy
Analyst Count 5
EPS Growth Next 3Y 23.5%
Revenue Growth Next 3Y N/A
Earnings Date Nov 12, 2026
EPS Estimate (next Q) -$0.67
EPS Growth Est (next Q) -51.8%
Revenue Est (next Q) N/A
Revenue Growth Est (next Q) N/A
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $22.00
Price Target Upside 107.5%
Cash Flow
Operating Cash Flow $-152.97M
Free Cash Flow $-154.59M
Adj. Free Cash Flow $-159.59M
FCF Per Share -$2.69
OCF Per Share -$2.66
OCF/S Ratio 0.0%
Income Statement
Revenue $0
Gross Profit $-30.21K
Operating Income $-177.17M
EBITDA $-177.05M
Net Income $-183.27M
EPS (Diluted) -$5.51
Revenue / Employee N/A
Profit / Employee $-1.83M
Employees 100
Add to Watchlist
Select watchlists to add or remove HELP